<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03401762</url>
  </required_header>
  <id_info>
    <org_study_id>STU00203644</org_study_id>
    <nct_id>NCT03401762</nct_id>
  </id_info>
  <brief_title>Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke</brief_title>
  <official_title>Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shirley Ryan AbilityLab</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to explore the feasibility of using a wearable device, called a&#xD;
      myoelectric-computer interface (MCI), to improve arm movement in people who have had a&#xD;
      stroke.&#xD;
&#xD;
      Impaired arm movement after stroke is caused not just by weakness, but also by impaired&#xD;
      coordination between joints due to abnormal co-activation of muscles. These abnormal&#xD;
      co-activation patterns are thought to be due to abnormal movement planning.The MCI aims to&#xD;
      reduce abnormal co-activation by providing feedback about individual muscle activations.&#xD;
&#xD;
      This randomized, controlled, blinded study will test the home use of an MCI in chronic and&#xD;
      acute stroke survivors.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2018</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants will be blinded as to sham vs. intervention, but not as to which interventional arm.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Wolf Motor Function Test</measure>
    <time_frame>baseline to 6 weeks</time_frame>
    <description>Timed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Assessment - Upper Extremity (UE)</measure>
    <time_frame>baseline to 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Activity Log</measure>
    <time_frame>baseline to 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Ashworth Scale</measure>
    <time_frame>baseline to 6 weeks</time_frame>
    <description>Total score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Assessment UE</measure>
    <time_frame>baseline to 10 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wolf Motor Function Test</measure>
    <time_frame>baseline to 10 weeks</time_frame>
    <description>Timed</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Stroke</condition>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Chronic stroke MCI Electromyogram (EMG) pairs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Decoupling 2 muscles at a time with MCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic stroke MCI EMG triplets</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Decoupling 3 muscles at a time with MCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic stroke MCI while reaching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Decoupling muscles with MCI while reaching to targets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic stroke Sham MCI</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute stroke MCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Decoupling muscles with MCI in acute stroke subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute stroke Sham MCI</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Acute stroke subjects sham comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>MCI</intervention_name>
    <description>EMG-controlled game</description>
    <arm_group_label>Acute stroke MCI</arm_group_label>
    <arm_group_label>Chronic stroke MCI EMG triplets</arm_group_label>
    <arm_group_label>Chronic stroke MCI Electromyogram (EMG) pairs</arm_group_label>
    <arm_group_label>Chronic stroke MCI while reaching</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sham MCI</intervention_name>
    <description>Sham control game</description>
    <arm_group_label>Acute stroke Sham MCI</arm_group_label>
    <arm_group_label>Chronic stroke Sham MCI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Chronic stroke participants&#xD;
&#xD;
          -  Hemiparesis from first ever stroke at least 6 months prior to screening&#xD;
&#xD;
          -  Severe motor impairment (FMA of 7-30)&#xD;
&#xD;
          -  At least some voluntary shoulder and elbow muscle activation.&#xD;
&#xD;
        Acute stroke participants&#xD;
&#xD;
          -  Hemiparesis from first ever stroke within the past 14 days&#xD;
&#xD;
          -  Severe motor impairment (FMA of 3-20), or total Manual Motor Score of 1-8 combined in&#xD;
             Shoulder Abduction and Finger Extensors&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cognitive impairment with at least moderately impaired attention, or unable to follow&#xD;
             instructions of the MCI task&#xD;
&#xD;
          -  Visual impairment (such as hemianopia) preventing full view of the screen&#xD;
&#xD;
          -  Anesthesia or neglect in the affected arm, or visual hemineglect (score of 2 on the&#xD;
             NIH Stroke Scale Extinction and Inattention subtest).&#xD;
&#xD;
          -  Participation in another study on the affected arm within 6 weeks of enrollment or any&#xD;
             pharmacological study&#xD;
&#xD;
          -  Inability to understand or follow commands in English due to aphasia or other reason&#xD;
&#xD;
          -  Diffuse or multifocal infarcts&#xD;
&#xD;
          -  Substantial arm pain preventing participation for 90 minutes a day&#xD;
&#xD;
          -  New spasticity treatment (pharmacological or Botox)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marc W Slutzky, MD, PhD</last_name>
    <phone>3125034653</phone>
    <email>mslutzky@northwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Blas Garcia-Canga</last_name>
    <email>blas.garcia-canga@northwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>January 9, 2018</study_first_submitted>
  <study_first_submitted_qc>January 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>November 30, 2020</last_update_submitted>
  <last_update_submitted_qc>November 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Marc Slutzky</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

